This episodes highlight a recent publication of the phase 3 clinical trial of dapagliflozine for  COVID-19 patients with cardiometabolic risk factors. <a rel="payment" href="https://www.patreon.com/bioxpressions">Support the show</a> (https://www.patreon.com/bioxpressions)

This episodes highlight a recent publication of the phase 3 clinical trial of dapagliflozine for COVID-19 patients with cardiometabolic risk factors. Support the show (https://www.patreon.com/bioxpressions)

This episodes highlight a recent publication of the phase 3 clinical trial of dapagliflozine for&nbsp; COVID-19 patients with cardiometabolic risk factors. <a href="https://www.patreon.com/bioxpressions" rel="noopener noreferrer">Support the show</a> (https://www.patreon.com/bioxpressions)

Highlights: Phase 3 Clinical Trial of Dapagliflozin

This weekly podcast brings you information from reviewed science articles about the molecular and systemic effects of plant-derived products, plant-based foods, vaccines, and medicines on the human body. Extras will include the timeline of drug discovery, biographies of drug discoverers, summaries of biomolecules, and more.

Share Highlights: Phase 3 Clinical Trial of Dapagliflozin

Sign up to save your podcasts

Highlights: Phase 3 Clinical Trial of Dapagliflozin

Highlights: Phase 3 Clinical Trial of Dapagliflozin